Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
about
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryRelationship and interactions of curcumin with radiation therapyCurcumin - Pharmacological Actions And its Role in Oral Submucous Fibrosis: A ReviewCurcumin and tumor immune-editing: resurrecting the immune systemAntioxidants in liver healthNatural compounds as anticancer agents: Experimental evidenceAge-related difference in susceptibility of Apc(Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcuminA multi-targeted approach to suppress tumor-promoting inflammationA chemical analog of curcumin as an improved inhibitor of amyloid Abeta oligomerizationImprovement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.Dose escalation of a curcuminoid formulationLiver S9 Fraction-Derived Metabolites of Curcumin Analogue UBS109.Dimethoxycurcumin, a structural analogue of curcumin, induces apoptosis in human renal carcinoma caki cells through the production of reactive oxygen species, the release of cytochrome C, and the activation of caspase-3.Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells.Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth.Curcumin: An age-old anti-inflammatory and anti-neoplastic agent.Pharmacokinetics of curcumin conjugate metabolites in healthy human subjectsApolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid.Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin.Curcumin: from ancient medicine to current clinical trials.Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease.Dimethoxycurcumin, a Synthetic Curcumin Analogue, Induces Heme Oxygenase-1 Expression through Nrf2 Activation in RAW264.7 Macrophages.Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis modelColorectal cancer: chemopreventive role of curcumin and resveratrol.4-Hydroxy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway: potential for prostate cancer management.Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism.Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry.Eliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs).Unraveling curcumin degradation: autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione.Advanced drug delivery systems of curcumin for cancer chemopreventionSmall molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseasesMouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993).Synthesis of novel C5-curcuminoid-fatty acid conjugates and mechanistic investigation of their anticancer activityBeyond Yellow Curry: Assessing Commercial Curcumin Absorption TechnologiesHexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells.Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process?Introduction of Methyl Groups at C2 and C6 Positions Enhances the Antiangiogenesis Activity of CurcuminEffects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats.Oxidative metabolites of curcumin poison human type II topoisomerases.
P2860
Q24630927-8E426066-2B3A-4748-8B26-8D85549E0EEBQ26746150-C2A094FE-14E6-40B7-A2A7-FBB3560A5BCEQ26777841-EFDA6336-68C3-4005-980E-43E511C48C2EQ26783491-1BBF20FE-6D7B-434D-9774-3013233AA283Q26799415-A5BC9972-8DF1-4EC5-B0C2-7E901960F769Q26823107-CA2AE23C-5651-4956-9087-3361C749D329Q28196338-B3FAAD58-B654-45B6-B4E3-E3B0290D9868Q28393278-C9E5C24B-2F73-4C4C-A34C-68497CAEA79BQ28481562-D8C57199-8482-474A-A1A9-28BCFD0E6B32Q30426968-E9B538C1-E40A-4C7D-AD24-6BC47B55D8C6Q33236898-D263F32A-DB9F-4826-B685-729FCFFDB47DQ33636519-A883E0DF-E267-4C17-A103-89249319D933Q33789917-907179C5-6D6C-4DDC-9D30-8F6B8922FB46Q33827813-7F2BAD9D-C80B-403A-BD18-EBB0EE5EB495Q33831661-6611C17D-9C1C-4A69-83E1-1572BDE34B7FQ33892483-7AAB2726-7252-47B2-880D-C1238A6A5636Q33896515-85120F35-F747-470B-8230-C53875B946ECQ34069410-5525FBDB-6958-4BB6-BC59-F3D5C2F0C56DQ34384585-328EDD89-9414-4FFC-80BA-F36212F27647Q34488862-B588ECEE-423F-47EB-810D-E8BE0FF7A4D5Q34589151-402E43D0-4B72-4BD8-AC36-69E190D19815Q34590604-B8B72464-A1A0-4A00-8566-493EEE05B8E2Q34603783-BD86205F-AB4D-468C-AB50-CD2A227CF0CAQ34608483-7A9C6FA9-44C4-45D0-89C8-4AE11B54DF0BQ34624184-8C8704DE-097A-4E5C-86BC-CDFBA67E58D0Q34771742-7D5FF48D-9111-4558-869D-FA701E6A5C10Q34835398-6687D285-B9D9-44F4-B5B1-1F10727EEE57Q34885283-03BDE815-CBEE-45FD-9F70-9A7A3A9C0E58Q35034180-FC33669C-442D-47FE-8CAD-F92B1CA22B8FQ35103935-50DDA05E-07BD-4D5D-AD35-C89F8A0B63E0Q35150975-B4D7C083-DB79-4E58-A840-BB809B8D3BD2Q35224775-350774B4-4BC9-4502-91F8-76DF58CC53ADQ35360274-77DB6E75-192B-4F74-9FEB-0FBEE4C22B36Q35657335-93673B5A-A2E4-45CD-A42D-4099F1798DE5Q35955023-903F7347-3606-49EC-99B6-193366A9FB21Q35963749-FAAE5E80-F534-499D-874B-8EDE5D642C3CQ36018435-AFCC1B58-6F6F-4A4F-A656-5BFC8ED7C8E7Q36099321-8EE6308A-3F09-4DE5-9E41-02D08C4622D7Q36492613-A81C2C2F-32C4-42FB-B79F-D1204FCFA17CQ36520921-E3ABC38A-4CDE-46C7-90AA-BA1B6ABF93B9
P2860
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Characterization of metabolite ...... d prostaglandin E2 production.
@ast
Characterization of metabolite ...... d prostaglandin E2 production.
@en
type
label
Characterization of metabolite ...... d prostaglandin E2 production.
@ast
Characterization of metabolite ...... d prostaglandin E2 production.
@en
prefLabel
Characterization of metabolite ...... d prostaglandin E2 production.
@ast
Characterization of metabolite ...... d prostaglandin E2 production.
@en
P2093
P1433
P1476
Characterization of metabolite ...... d prostaglandin E2 production.
@en
P2093
M Williams
R Verschoyle
P304
P407
P577
2001-02-01T00:00:00Z